BioCryst Pharmaceuticals | Zobowiązania Handlowe





Zobowiązania Handlowe Zmiana Data
Alnylam Pharmaceuticals USD 115.72M 1.87M 2025-12
BioCryst Pharmaceuticals USD 5.57M 3.02M 2025-09
Chugai Pharma JPY 127.25B 48.35B 2025-12
Daiichi Sankyo JPY 568.5B 16.84B 2025-12
DBV Technologies USD 39.82M 972K 2025-09
Enanta Pharmaceuticals USD 1.88M 63K 2025-12
Gilead Sciences USD 808M 226M 2025-09
GlaxoSmithKline GBP 15.38B 294M 2025-12
Glaxosmithkline GBP 21.07B 7.42B 2025-09
Incyte USD 1.63B 1.46B 2025-12
Ionis Pharmaceuticals USD 14.33M 8.47M 2025-09
Karyopharm Therapeutics USD 5.39M 2.8M 2025-09
Neurocrine Biosciences USD 545.5M 425.6M 2025-12
Novavax USD 15.23M 35.37M 2025-09
PTC Therapeutics USD 45.49M 8.87M 2025-12
Regeneron Pharmaceuticals USD 5.83B 4.93B 2025-12
Roche Holding CHF 5.78B 1.27B 2025-12
Sarepta Therapeutics USD 280.84M 186.83M 2025-12
Ultragenyx Pharmaceutical USD 40.57M 6.33M 2025-09
Vertex Pharmaceuticals USD 3.43B 600.9M 2025-12


BioCryst Pharmaceuticals Zobowiązania Handlowe - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Mar 2026.